Back to Home
Switchpoint Bio news
Switchpoint Bio appears in 1 story we have published in November 2026, mostly in our Business coverage. It is most often reported alongside Treehouse Delmar Investments.
Latest development
Switchpoint Bio raises $5.3M to develop AI-powered blood tests for drug development
Switchpoint Bio has emerged from stealth with $5.3 million in pre-seed funding. The Helsinki-Cambridge startup is developing blood tests that use epigenomics and AI to track how patients’ biology changes during treatment—without the need for invasive biopsies. Treehouse Delmar Investments led the round.
11 November 2026
